摘要
目的比较简化MDRD公式与慢性肾脏病学流行病学合作研究(CKD—EPI)公式在评估外周动脉疾病(peripheral arterial disease,PAD)患者肾小球滤过率(GFR)中的适用性。方法采用回顾性队列研究,选择2005年在上海市和北京市8家医院被确诊为PAD的841例患者作为研究对象,分别利用MDRD与CKD—EPI公式估算肾小球滤过率(eGFR),应用Spearman相关性检验、Bland-Altman曲线和Kappa检验比较两种方程估算GFR的相关性和一致性,并利用净重新分类指数(net re-classification improvement,NRI)比较2个公式对死亡风险的评估能力。结果eGFRMDRD高于eGFRCKD-EPI,均值差为4.33ml·min^-1·(1.73m^2)^-1,但两者评估eGFR值的相关性和一致性良好(Kappa值为0.749,r=0.991,P〈0.05)。以MDRD为标准,CKD-EPI公式改变了152例(18.1%)患者的分期,其中9例(1.1%)分期上调,143例(17.0%)分期下调。全因死亡NRI为0.059(P〈0.05),心血管死亡NRI为0.022(P〉0.05),提示CKD—EPI公式仅对全因死亡的风险评估能力优于MDRD。结论CKD-EPI公式在PAD患者中的应用并未显著优于MDRD公式。
Objective To compare the performance of newly developed Chronic Kidney Disease Epidemiology Collaboration (CKD- EPI) equation and Modification of Diet in Renal Disease (MDRD) equation in patients with peripheral arterial diseases (PAD). Methods A total of 841 patients with PAD were enrolled in this retrospective cohort study. Estimated glomerular filtration rate (eGFR), calculated by MDRD and CKD-EPI equation respectively, was analyzed by Spearman correlation analysis, Bland-Ahman method and Kappa test for the evaluation of correlation and consistency. Net re- classification improvement (NRI) was adopted to compare the death risk assessment between these two equations. Results Although the eGFR was 4.33 ml. min^-1. (1.73 m^2)^-1 higher with MDRD equation than with CKD- EPI equation, there were still significant correlation and fine consistency between eGFRMDRD and eGFRCKD-EPI (Kappa: 0.749, r=0.991, P〈 0.05). The CKD- EPI equation reclassified 9 (1.1%) patients upward to higher eGFR category and 143 (17.0%) patients downward to lower eGFR category. Besides, the performance of risk assessment for all-cause death was better with CKD- EPI equation than with MDRD equation (NRI=0.059, P 〈 0.05), which was not the case for cardiovascular death (NRI=0.022, P 〉 0.05). Conclusions There is no solid evidence suggesting that CKD- EPI equation performs better than MDRD equation.
出处
《中华肾脏病杂志》
CAS
CSCD
北大核心
2015年第10期755-759,共5页
Chinese Journal of Nephrology
基金
上海市卫生和计划生育委员会资助项目(201440312)